✦ LIBER ✦
The tp53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non–small cell lung cancer
✍ Scribed by Daniela Kandioler-Eckersberger; S. Kappel; M. Mittlböck; G. Dekan; C. Ludwig; E. Janschek; R. Pirker; E. Wolner; F. Eckersberger
- Book ID
- 114062967
- Publisher
- CTSNet
- Year
- 1999
- Tongue
- English
- Weight
- 46 KB
- Volume
- 117
- Category
- Article
- ISSN
- 1097-685X
No coin nor oath required. For personal study only.